Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

20121,080 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 13, Issue 5, pp. 459-465

Field-Weighted Citation Impact: 67.87